Business Wire | Jan 16, 2021 11:12AM EST

ANCHIANO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Anchiano Therapeutics Ltd. - ANCN

Jan. 16, 2021

NEW ORLEANS--(BUSINESS WIRE)--Jan. 16, 2021--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Anchiano Therapeutics Ltd. (NasdaqGS: ANCN) with Chemomab Ltd. pursuant to which Anchiano shareholders will end up owning only approximately 10% of the combined company, prior to additional PIPE financing. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-ancn/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Kahn Swick & Foti, LLC 1100 Poydras St., Suite 3200 New Orleans, LA 70163

View source version on businesswire.com: https://www.businesswire.com/news/home/20210116005019/en/

CONTACT: Kahn Swick & Foti, LLC Lewis S. Kahn, Managing Partner lewis.kahn@ksfcounsel.com 855-768-1857